Atlas Trials

A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease

Clinical trial NCT05286853 · WITHDRAWN

Trial details

NCT number
NCT05286853
Sponsor
Prokidney
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusChronic Kidney Diseases
Start date
2024-07-17
Primary completion
2024-09-03
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.